Roumell Asset Management, LLC Aridis Pharmaceuticals, Inc. Put Options Transaction History

Roumell Asset Management, LLC

  • $51 Million
  • Q2 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding ARDS

# of Institutions
2
Shares Held
50.2K
Call Options Held
0
Put Options Held
0
View Full List

About Aridis Pharmaceuticals, Inc.

ARDS Quotes by TradingView
  • Ticker ARDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,701,600
  • Description
  • Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...
More about ARDS
Track This Portfolio

Track Roumell Asset Management, LLC Portfolio

Follow Roumell Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roumell Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roumell Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email